PE20011033A1 - Compuestos esteroides con un anillo ciclopropano con actividad androgenica - Google Patents

Compuestos esteroides con un anillo ciclopropano con actividad androgenica

Info

Publication number
PE20011033A1
PE20011033A1 PE2000001285A PE0012852000A PE20011033A1 PE 20011033 A1 PE20011033 A1 PE 20011033A1 PE 2000001285 A PE2000001285 A PE 2000001285A PE 0012852000 A PE0012852000 A PE 0012852000A PE 20011033 A1 PE20011033 A1 PE 20011033A1
Authority
PE
Peru
Prior art keywords
alkyl
androgenic activity
steroid compounds
compounds
acyl
Prior art date
Application number
PE2000001285A
Other languages
English (en)
Spanish (es)
Inventor
Roberta Buma Bursi
Jaap Van Der Louw
Dirk Leysen
Gooijer Marcel Evert De
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20011033A1 publication Critical patent/PE20011033A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
PE2000001285A 1999-12-02 2000-12-01 Compuestos esteroides con un anillo ciclopropano con actividad androgenica PE20011033A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02

Publications (1)

Publication Number Publication Date
PE20011033A1 true PE20011033A1 (es) 2001-10-11

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001285A PE20011033A1 (es) 1999-12-02 2000-12-01 Compuestos esteroides con un anillo ciclopropano con actividad androgenica

Country Status (27)

Country Link
US (1) US6706700B2 (enExample)
EP (1) EP1237904B1 (enExample)
JP (1) JP2003515543A (enExample)
CN (1) CN1166680C (enExample)
AR (1) AR026655A1 (enExample)
AT (1) ATE317396T1 (enExample)
AU (1) AU778017B2 (enExample)
CA (1) CA2390226A1 (enExample)
CO (1) CO5251441A1 (enExample)
CY (1) CY1106086T1 (enExample)
CZ (1) CZ301376B6 (enExample)
DE (1) DE60025958T2 (enExample)
DK (1) DK1237904T3 (enExample)
ES (1) ES2258037T3 (enExample)
HK (1) HK1047596B (enExample)
HU (1) HUP0203611A3 (enExample)
IL (1) IL149424A (enExample)
MX (1) MXPA02004939A (enExample)
NO (1) NO322422B1 (enExample)
NZ (1) NZ518753A (enExample)
PE (1) PE20011033A1 (enExample)
PL (1) PL202999B1 (enExample)
RU (1) RU2242479C2 (enExample)
SK (1) SK287095B6 (enExample)
TW (1) TWI275593B (enExample)
WO (1) WO2001040255A2 (enExample)
ZA (1) ZA200203536B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5209600A (en) * 1999-04-06 2000-10-23 Akzo Nobel N.V. Orally active androgens
RS51490B (sr) * 2002-01-21 2011-04-30 N.V. Organon POSTUPAK ZA IZRADU 7α-METILSTEROIDA
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PL2764008T3 (pl) * 2011-10-07 2017-04-28 Estetra S.P.R.L. Sposób wytwarzania estetrolu
JP6863547B2 (ja) 2015-06-18 2021-04-21 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
JP6866560B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) * 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) * 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
WO2000053619A1 (en) * 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens

Also Published As

Publication number Publication date
HUP0203611A3 (en) 2004-07-28
JP2003515543A (ja) 2003-05-07
ZA200203536B (en) 2003-08-04
SK287095B6 (sk) 2009-12-07
CZ20021894A3 (cs) 2002-08-14
EP1237904A2 (en) 2002-09-11
AU778017B2 (en) 2004-11-11
WO2001040255A2 (en) 2001-06-07
ATE317396T1 (de) 2006-02-15
CZ301376B6 (cs) 2010-02-03
NO20022564D0 (no) 2002-05-30
NO322422B1 (no) 2006-10-02
CN1402735A (zh) 2003-03-12
ES2258037T3 (es) 2006-08-16
TWI275593B (en) 2007-03-11
CA2390226A1 (en) 2001-06-07
US6706700B2 (en) 2004-03-16
DK1237904T3 (da) 2006-06-06
DE60025958T2 (de) 2006-07-27
CN1166680C (zh) 2004-09-15
AU2838301A (en) 2001-06-12
NZ518753A (en) 2004-05-28
SK7582002A3 (en) 2002-09-10
DE60025958D1 (de) 2006-04-20
IL149424A (en) 2007-05-15
EP1237904B1 (en) 2006-02-08
IL149424A0 (en) 2002-11-10
PL355689A1 (en) 2004-05-17
HK1047596B (en) 2006-04-21
PL202999B1 (pl) 2009-08-31
CO5251441A1 (es) 2003-02-28
US20030100543A1 (en) 2003-05-29
NO20022564L (no) 2002-05-30
RU2242479C2 (ru) 2004-12-20
MXPA02004939A (es) 2003-05-23
HUP0203611A2 (hu) 2003-03-28
CY1106086T1 (el) 2011-06-08
AR026655A1 (es) 2003-02-19
HK1047596A1 (en) 2003-02-28
WO2001040255A3 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
PE20011033A1 (es) Compuestos esteroides con un anillo ciclopropano con actividad androgenica
PE20010112A1 (es) Compuestos no esteroides como moduladores del receptor glucocorticoide
PE20010330A1 (es) Androgenos oralmente activos
NO924755D0 (no) Metoder og preparater for anvendelse i forbindelse med befruktningsinhibering og i behandling av benigne gynekologiske sykdommer
SE8603046D0 (sv) Substituted androsta-1,4-diene-3,17-diones and process for their preparation
AR034091A1 (es) Composiciones farmaceuticas que contienen un modulador selectivo del receptor de estrogeno; metodos de tratamiento y prevencion de la resistencia a la insulina y un compuesto modulador selectivo del receptor de estrogeno
ATE87473T1 (de) Arzneimittel zur inhibition von hautfalte.
HUP9901136A2 (hu) N,N-dimetil-2-(aril-tio)-benzil-amin-származékok és sóik, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
HUP0002311A2 (hu) Ergolinszármazékok és szomatosztatin receptorként való alkalmazásuk
PE27497A1 (es) Derivados de 1,5 benzodiazepina
ES2107806T3 (es) Nuevos esteroides.
Tesone et al. Steroid biosynthesis in the gonads of the teleost fish Jenynsia lineata
ATE44282T1 (de) 6-oder-7-methylenandrosta-1,4-dien-3,17-dionderivate und verfahren zu ihrer herstellung.
GB9610031D0 (en) Chemical compounds
NO20021079L (no) Ikke-aromatiske östrogene steroider med en hydrogensubstituent i posisjon 11
PE20020472A1 (es) Uso de un inhibidor del receptor de progesterona para inhibir la fijacion de factores de crecimiento en celulas tumorales
PE20001489A1 (es) ESTEROIDE (14ß,17O)-17-(HIDROXIMETILO) CON ACTIVIDAD ANDROGENA
CA2486495A1 (en) 9-alpha-substituted estratrienes as selectively active estrogens
WO2001053321A3 (en) Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers
MX9802126A (es) Compuestos heterociclicos novedosos.
PE20030442A1 (es) 17alfa-hidroxi-14beta-esteroides con actividad androgenica y estabilidad metabolica
PE20020688A1 (es) ESTEROIDES ANDROGENICOS DE TIPO (14ß,17O)-17-(HIDROXIMETILO)
AR034194A1 (es) Un compuesto esteroide, su uso, una composicion farmaceutica que lo comprende y un kit para la anticoncepcion masculina
ATE40140T1 (de) Aromatase inhibierende steroide.
FR2181798A1 (en) 17-cyclo octenyloxy steroids - having androgenic and anabolic activity

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed